Adverse Event Clinical Trials

45 recruitingLast updated: June 18, 2026

There are 45 actively recruiting adverse event clinical trials across 15 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1. Top locations include Guangzhou, Guangdong, China, Beijing, Beijing Municipality, China, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Adverse Event Trials at a Glance

45 actively recruiting trials for adverse event are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Boston. Lead sponsors running adverse event studies include AHS Cancer Control Alberta, Brigham and Women's Hospital, and Sun Yat-sen University.

Browse adverse event trials by phase

Treatments under study

About Adverse Event Clinical Trials

Looking for clinical trials for Adverse Event? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adverse Event trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adverse Event clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 45 trials

Recruiting
Phase 2

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma

MelanomaImmune Checkpoint InhibitorImmune-related Adverse Event
Sun Yat-sen University55 enrolled2 locationsNCT07644897
Recruiting

Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events

OncologyPatient SafetySerious Adverse Events+1 more
St Vincent's University Hospital, Ireland100 enrolled1 locationNCT07592234
Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

Adverse EventsIntubation Complication
Thomas Riva105,000 enrolled8 locationsNCT05804188
Recruiting

Factors for Prolonged Hospital Stays in Patients Undergoing ERCP

Post-ERCP Adverse EventsERCP Complications
Air Force Military Medical University, China504 enrolled2 locationsNCT07568626
Recruiting
Not Applicable

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

Adverse EventMultiple Chronic Conditions
Brigham and Women's Hospital1,300 enrolled2 locationsNCT05282654
Recruiting
Phase 4

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Perioperative Respiratory Adverse EventsHigh-RiskRespiratory Hypersensitivity+2 more
Sun Yat-sen University204 enrolled2 locationsNCT06624696
Recruiting
Not Applicable

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

Health DisparitiesPatient SafetyQuality Improvement+3 more
Boston Children's Hospital656 enrolled1 locationNCT05407129
Recruiting
Not Applicable

TEAS for Sedation During ERCP: A Multicenter Trial

Procedural PainEndoscopic Retrograde CholangiopancreatographyConscious Sedation Adverse Event+1 more
Beijing 302 Hospital130 enrolled1 locationNCT07440342
Recruiting
Phase 2

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta94 enrolled1 locationNCT06860542
Recruiting
Phase 4

Safety of RSV Preventive Monoclonal Antibody

FeverAdverse Event Following Immunisation
Duke University524 enrolled6 locationsNCT07158814
Recruiting

Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III

Adverse EventsAirway Complication of Anesthesia
Insel Gruppe AG, University Hospital Bern40,000 enrolled5 locationsNCT06117176
Recruiting

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Immune-related Adverse Events
Peking Union Medical College Hospital500 enrolled1 locationNCT07453342
Recruiting
Phase 2

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811
Recruiting
Not Applicable

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Quality of LifeObjective Response RatePathological Complete Remission+1 more
The Second Hospital of Shandong University25 enrolled1 locationNCT07430579
Recruiting

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Solid TumorImmune-related Adverse EventsImmunotherapy Toxicity
Shantou University Medical College940 enrolled6 locationsNCT07357636
Recruiting

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

CancerCancer;Cardiovascular;Adverse Events
Sixth Affiliated Hospital, Sun Yat-sen University5,000 enrolled1 locationNCT07058454
Recruiting

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Solid TumorsSjogren SyndromeImmune-related Adverse Events+3 more
Hospital Universitario Araba300 enrolled1 locationNCT07249060
Recruiting
Phase 4

Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.

Perioperative Respiratory Adverse EventsAnesthesia Outcomes
Telethon Kids Institute200 enrolled1 locationNCT07000877
Recruiting

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

CancerImmune-Mediated HepatitisImmune-related Adverse Events
University Hospital, Basel, Switzerland63 enrolled2 locationsNCT07167251
Recruiting

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Adverse EventAcute Myocardial Infarction
Yu Bo15,000 enrolled18 locationsNCT05862103